MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 11 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $23,000 | 0.0% | 25,000 | 0.0% | 0.00% | – |
Q1 2020 | $23,000 | 0.0% | 25,000 | 0.0% | 0.00% | – |
Q4 2019 | $23,000 | 0.0% | 25,000 | 0.0% | 0.00% | – |
Q3 2019 | $23,000 | 0.0% | 25,000 | 0.0% | 0.00% | – |
Q2 2019 | $23,000 | 0.0% | 25,000 | 0.0% | 0.00% | – |
Q1 2019 | $23,000 | 0.0% | 25,000 | 0.0% | 0.00% | – |
Q4 2018 | $23,000 | +228.6% | 25,000 | +257.1% | 0.00% | – |
Q3 2017 | $7,000 | +75.0% | 7,000 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | -20.0% | 7,000 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | -16.7% | 7,000 | 0.0% | 0.00% | – |
Q4 2016 | $6,000 | -33.3% | 7,000 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | +125.0% | 7,000 | +75.0% | 0.00% | – |
Q2 2016 | $4,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|